Silo Pharma, Inc. (SILO)
2.15
0.00 (0.00%)
USD |
NASDAQ |
Sep 10, 16:00
2.15
0.00 (0.00%)
After-Hours: 20:00
Silo Pharma Shareholders Equity (Quarterly) : 4.886M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.886M |
| March 31, 2026 | 5.682M |
| December 31, 2025 | 6.305M |
| September 30, 2025 | 5.009M |
| June 30, 2025 | 4.917M |
| March 31, 2025 | 4.011M |
| December 31, 2024 | 5.034M |
| September 30, 2024 | 6.782M |
| June 30, 2024 | 5.958M |
| March 31, 2024 | 5.292M |
| December 31, 2023 | 6.177M |
| September 30, 2023 | 7.497M |
| June 30, 2023 | 8.296M |
| March 31, 2023 | 9.444M |
| December 31, 2022 | 10.34M |
| September 30, 2022 | 11.85M |
| June 30, 2022 | 7.874M |
| March 31, 2022 | 8.503M |
| December 31, 2021 | 9.062M |
| September 30, 2021 | 10.15M |
| June 30, 2021 | 3.766M |
| March 31, 2021 | 4.228M |
| December 31, 2020 | 1.281M |
| September 30, 2020 | 2.070M |
| June 30, 2020 | 2.704M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.1382M |
| December 31, 2019 | 0.3771M |
| September 30, 2019 | 0.2987M |
| June 30, 2019 | 0.5029M |
| March 31, 2019 | 0.6927M |
| December 31, 2018 | |
| September 30, 2018 | 1.406M |
| June 30, 2018 | 1.305M |
| March 31, 2018 | 1.621M |
| December 31, 2017 | 1.603M |
| September 30, 2017 | 1.396M |
| June 30, 2017 | 1.915M |
| March 31, 2017 | 1.991M |
| December 31, 2016 | 1.246M |
| September 30, 2016 | 1.390M |
| June 30, 2016 | 1.821M |
| March 31, 2016 | 2.255M |
| December 31, 2015 | 2.360M |
| September 30, 2015 | 2.415M |
| June 30, 2015 | 2.864M |
| March 31, 2015 | 2.835M |
| December 31, 2014 | 2.769M |
| September 30, 2014 | 2.816M |
| June 30, 2014 | 2.491M |
| March 31, 2014 | 2.921M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.952M |
| Total Liabilities (Quarterly) | 1.066M |
| Current Ratio | 5.361 |